Decision rule identifies unprovoked VTE patients who can halt anticoagulation
PM 360,
AT THE ESC CONGRESS 2016 ROME (FRONTLINE MEDICAL NEWS) – Half of all women who experience a first unprovoked venous…
AT THE ESC CONGRESS 2016 ROME (FRONTLINE MEDICAL NEWS) – Half of all women who experience a first unprovoked venous…
1. Apixaban was found to be non-inferior to conventional therapy (i.e., enoxaparin followed by warfarin) in the treatment of…
The drug, Eliquis, currently approved in the US to prevent stroke, was shown to be just as effective in stopping blood clots as…
The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin…